DIAGNOSTIC TECHNOLOGY, INC. – Trademark Portfolio

Entity Type: 03

DIAGNOSTIC TECHNOLOGY, INC. holds 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 17 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. The owner is based in HAUPPAUGE, NY.

240 VANDERBILT MOTOR PARKWAY

HAUPPAUGE, NY 11785

21 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

DIAGNOSTIC TECHNOLOGY, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (17 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does DIAGNOSTIC TECHNOLOGY, INC. have?

DIAGNOSTIC TECHNOLOGY, INC. has 21 U.S. trademarks filed with the USPTO.

What trademark classes does DIAGNOSTIC TECHNOLOGY, INC. file in?

DIAGNOSTIC TECHNOLOGY, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What is DIAGNOSTIC TECHNOLOGY, INC.'s trademark registration success rate?

DIAGNOSTIC TECHNOLOGY, INC. has a 0% trademark registration rate, with 0 out of 21 resolved applications resulting in successful registration. Currently, 0 applications are pending review.